Inscriere cercetatori

Daca aveti cont Ad Astra si de Facebook, intrati pe pagina de profil pentru a da dreptul sa va logati pe site doar cu acest buton.

Site nou !

Daca nu va puteti recupera parola (sau aveti alte probleme), scrieti-ne la pagina de contact. Situl vechi se gaseste la adresa


Contrast enhanced ultrasound in assessing therapeutic response in ablative treatments of hepatocellular carcinoma.

Domenii publicaţii > Ştiinţe medicale + Tipuri publicaţii > Articol în revistã ştiinţificã

Autori: Sparchez Z, Radu P, Anton O, Socaciu M, Badea R

Editorial: Journal of Gastrointestinal and Liver Diseases, 18(2), p.243-248. , 2009.


Percutaneous ablative methods guided by imaging techniques are considered nowadays curative treatment for early HCC in patients who are not candidates for liver transplantation and surgical resection. The final goal of all ablative treatments is to achieve complete destruction of neoplastic tissue by disruption of tumor vascularity. The best way to demonstrate the efficacy of any ablative methods noninvasively is to demonstrate that the blood supply has been disrupted both inside and at the periphery of the tumor by means of imaging methods. Contrast-enhanced ultrasound (CEUS) with second generation contrast agents is almost as sensitive as CT (considered to be the gold standard) in depicting the residual tumor after an ablation. Moreover, CEUS can be used before ablation to plan the treatment, during the procedure to guide the needle insertion, or immediately after to determine whether the tumor has been ablated or needs additional treatment which can be performed in the same session

Cuvinte cheie: Hepatocellular carcinoma - percutaneous ablative treatment - contrast enhanced ultrasound - treatment response.